Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral Sells 20,000 Shares

Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Doximity Stock Down 1.0 %

Shares of NASDAQ:DOCS traded down $0.61 during midday trading on Wednesday, reaching $58.14. The company’s stock had a trading volume of 2,293,281 shares, compared to its average volume of 1,492,431. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The firm has a market capitalization of $10.85 billion, a PE ratio of 66.82, a P/E/G ratio of 4.68 and a beta of 1.39. The stock has a fifty day moving average of $54.89 and a 200 day moving average of $45.13.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The company had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. Doximity had a return on equity of 19.79% and a net margin of 33.69%. During the same quarter in the previous year, the company earned $0.18 EPS. Sell-side analysts anticipate that Doximity, Inc. will post 0.88 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Doximity

Several institutional investors have recently made changes to their positions in DOCS. Bank of Montreal Can increased its holdings in Doximity by 43.4% in the second quarter. Bank of Montreal Can now owns 21,412 shares of the company’s stock valued at $599,000 after buying an additional 6,480 shares in the last quarter. Creative Planning grew its position in shares of Doximity by 20.1% during the 2nd quarter. Creative Planning now owns 19,433 shares of the company’s stock valued at $544,000 after acquiring an additional 3,251 shares during the period. Sanctuary Advisors LLC purchased a new position in shares of Doximity in the 2nd quarter valued at about $270,000. GAMMA Investing LLC raised its holdings in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares during the period. Finally, Perpetual Ltd purchased a new position in Doximity during the third quarter worth approximately $441,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on DOCS shares. KeyCorp cut their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and issued a $65.00 target price (up previously from $37.00) on shares of Doximity in a research note on Friday, November 8th. Stephens initiated coverage on shares of Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target for the company. Barclays boosted their price objective on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group began coverage on shares of Doximity in a report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price target on the stock. Thirteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $53.12.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.